Since nearly the entire medical profession has lost its collective mind and is pushing mutable, low epitope, whole population experimental vaccination for a disease with a 0.15% IFR & an average fatality age of 84..

Heres a couple of questions I'd quite like answered

1/ Where are the results of CRP levels (inflammation markers) in the vaccinated? Pre and post vaccination.. What are the mean times towards CRP levels returning to normal & is there a statistically relevant increase in CRP above base levels in the longer term?

2/ If induced spike protein production via RNA or DNA vaccines is transient.. where is the PCR test data showing spike protein levels decreasing over time post vaccination?.. Have their been individuals where even lower levels persist?

3/ What studies have been done on anaphylaxis and allergic reaction in those with markedly low ACE2 receptor density?

4/ If the rna itself, the adenovirus DNA vector, and the spike protein are all potentially capable of causing clotting cascade injury.. and the spike protein capable of causing compliment cascade injury.. why has platelet depletion not been considered in vulnerable

5/ The NHS is actively advertising for patients with liver disease to come forward for vaccination.. Are these individuals aware that there is no current safety or efficacy data for this cohort? that they are participating in a high risk live trial & may be at an increased risk?

6/ With the potential for downstream vascular injury from compliment and clotting cascade effects.. what data supports annual / multi annual booster regimen and rules out the potential for cumulative injury?

7/ Re: point 1.. So here is what I can find for Pfizer.. all seems nice and regular doesn't it.. but wait.. the trial only uses individuals with pre-existing healthy CRP markers.. what data shows safety in those with inflammatory conditions like atherosclerosis, CV disease, etc?

The option isn't just vaccine or disease in these people.. there are highly effective therapeutics